US Veterinary Diagnostics Market 2025 – 2034

Reports Description

As per the US Veterinary Diagnostics Market analysis conducted by the CMI team, the US veterinary diagnostics market is expected to record a CAGR of 9.27% from 2025 to 2034. In 2025, the market size was USD 5.17 Billion. By 2034, the valuation is anticipated to reach USD 11.44 Billion.

Overview

The last few years have witnessed a rise in the adoption of various point-of-care (POC) diagnostic methods for veterinary purposes. They have enhanced the efficacy, standardization, and speed of veterinary diagnostics. The other advantage is that they need limited healthcare personnel and have the capacity to overcome the problem of less-experienced, cross-trained staff at various diagnostic services.

Active support from the government coupled with a rise in awareness amongst the owners of livestock has resulted in an increased demand for various animal disease diagnostic kits and tests, which is, in turn, likely to catalyze the US veterinary diagnostics market. Along these lines, The Michigan State University Veterinary Diagnostic Laboratory, in November 2023, was selected for enhancing diagnostic capabilities regarding early diagnosis of emerging ailments in the Midwest region. This partnership was monetarily supported by the US Department of Agriculture (USDA) Animal and Plant Health Inspection Service (APHIS).

Key Trends & Drivers

• Increase in Pet Ownership and Rising Expenditure on Animal Healthcare

The sizable rise in the rate of pet ownership is a major driver of the growth of the US veterinary diagnostics market. The companion animals such as cats, dogs, and exotic pets have turned out to be integral members of numerous households, particularly in the US

The emotional connection between pets and their owners is pushing them to proactively invest in their wellbeing and health, thereby generating demand for advanced diagnostics and early disease detection. This move does translate into higher spending regarding veterinary care. With an increasing number of pet owners investing in preventive screenings, check-ups, and sophisticated diagnostic tests for detecting and treating ailments such as renal disorders, diabetes, early-stage cancers, and infectious diseases at regular intervals, the US veterinary diagnostics market is expected to flourish during the forecast period.

What’s trending in the US Veterinary Diagnostics Market?

Technological advancements are the ongoing trend in the US veterinary diagnostics market. As such, early disease detection along with personalized treatment options for the pets are taking center stage. On these grounds, Antech, in September 2022, did expand its canine cancer diagnostic capabilities with novel molecular tests such as OncoK9 and SearchLight DNA for improving early detection. Such innovations facilitate integration of digital cytology, molecular diagnostics, and imaging technologies for extending support to veterinarians and improving outcomes for dogs battling cancer. Also, the US market is witnessing adoption of biomarker identification tools and DNA-based assays, which enhance diagnostic precision in veterinary oncology.

Key Threats

• Dearth of Skilled Diagnostic Specialists and Veterinary Professionals

The rise in the shortage of trained diagnostic specialists and veterinary professionals is amongst the significant restraints witnessed by the US veterinary diagnostics market. With a surge in demand for pet care, the gap between the increasing population of pets and the number of practicing vets is broadening, particularly the ones who are trained to interpret and operate complex diagnostic tools. Also, advanced modalities such as molecular biology, histopathology, radiology, etc. need specialized equipment as well as expertise for conducting and interpreting the tests precisely. The visible shortfall of trained personnel on this count is bound to hamper the US veterinary diagnostics market.

Opportunities

Rise in the integration of AI, digital health tools, and telemedicine in veterinary diagnostics does indicate a significant opportunity with regard to the transformation of the US veterinary diagnostics market. AI-powered diagnostics platforms do enable precise, quicker, and remote animal health assessments. The market players are also introducing wearable diagnostic devices such as health trackers and smart collars for pets. They help in monitoring behavioral changes, vital signs, and activity levels, thereby alerting the vets and pet owners regarding potential health issues before things get out of control. Integrating veterinary diagnostics with AI-assisted triage tools, cloud-based lab results, and digital health records improves the efficiency of diagnostic decision-making.

Category Wise Insights

By Product

• Consumables

Consumables such as reagents, test strips, and sample collection kits are necessary for animal health assessments at regular intervals. Their cost-effectiveness is making them ideal for early diagnosis of disease, inclusive of infectious diseases and parasitic infections and high throughput. For instance, ELISA kits are used to screen FeLV in cats during the routine check-ups, whereas lateral flow tests diagnose parvovirus in puppies at a faster rate. Also, technological advancements in automated analyzers and imaging tools are generating a higher need for compatible consumables. Furthermore, the rise in adoption of molecular diagnostics such as PCR does fuel demand for related kits and reagents.

• Reagents

Reagents are vital for rapid diagnostic tests used for detecting antibodies or antigens in animal blood and immunoassays such as ELISA, thereby helping in diagnosing numerous infections. Molecular diagnostics, inclusive of microarrays and PCRs, use reagents for identifying genetic markers and pathogens, thereby facilitating personalized treatment strategies and early disease detection.

Reagents are used in biochemistry and hematology analyzers for detecting diabetes, anemia, and liver issues through analysis of urine samples and blood. They are also important for POC diagnostic devices, as they enable faster clinical decision-making, particularly in remote locations or emergency situations.

• Kits

Veterinary diagnostic test kits are sizably contributing toward the growth of the US veterinary diagnostics market by offering rapid, cost-effective, and convenient solutions for detection of disease in both livestock and companion animals. The kits, especially the ones using technologies such as ELISA and PCR facilitate quicker turnaround times and enhanced precision, thereby facilitating targeted treatment and early detection of disease. This, in turn, results in better management of animal health, increased confidence of pet owners, and a reduction in economic losses for the producers of livestock.

• Equipment & Instruments

CT scanners, ultrasound, and digital radiography let vets visualize the internal structures with better clarity, thereby helping in diagnosing a broader spectrum of conditions. AI and ML are getting integrated into the diagnostic systems, thereby facilitating personalized treatment plans and predictive analytics. Their ability to diagnose a broader range of ailments, inclusive of complex cases, has resulted in a rise in demand for specialized diagnostic services and veterinary care.

By Testing Category

• Clinical Chemistry

Clinical chemistry implies the provision of essential tools to diagnose and monitor animal health. Rise in adoption of portable and automated chemistry analyzers coupled with advancements in multiplex testing, enables precise, quicker, and convenient diagnostics, thereby driving the demand for wellness screenings and preventive care.

Clinical chemistry tests inclusive of biochemical analysis of bodily fluids are important for monitoring and detecting several conditions in both livestock and companion animals. Such tests help in identifying abnormalities pertaining to kidney, liver, and electrolytes, along with chronic diseases such as kidney disease and diabetes.

• Microbiology

Advancements pertaining to molecular diagnostics, such as biomarker identification and DNA-based assays are important for early diagnosis, personalized treatment, and enhanced therapeutic decision-making. Molecular techniques such as genomic sequencing and PCR help in quickly identifying pathogens, even in complicated cases. Continual advancements with respect to molecular diagnostics like digital cytology are fueling the market further.

• Parasitology

Parasitology is coming up as one of the leading testing categories in the US POC diagnostics market. Parasitological tests are necessary to diagnose and manage parasitic infections in companion animals such as dogs and cats, which are witnessing a rise in ownership due to increasingly being looked upon as family members.

Parasitology also plays a significant role in the productivity and health of livestock, wherein diagnostic services help in identifying and addressing parasitic infections that could positively influence animal welfare, followed by the economic outcomes.

• Histopathology

Histopathology implies animal tissues’ microscopic study. Advancements in AI-powered image analysis and digital pathology are driving the expansion of the histopathology sector, thereby resulting in more accurate and quicker results. Histopathology is vital for diagnosing as well as staging several animal cancers, inclusive of lymphoma in dogs. It also helps in tracking the effectiveness of treatments, especially in chronic conditions.

• Cytopathology

Cytopathology helps the vets for examining tissues as well as cells from various types of cancers (like lymph nodes and skin masses) using fine needle aspiration for determining if a condition is malignant or benign. Moreover, advancements in the digital cytology systems, such as the one that Antech Diagnostics has launched, allow for fast evaluation of various cytological samples, thereby helping in faster diagnoses as well as treatment decisions. Rise in popularity of pet insurance is also helping in market expansion, as the pets who are insured have a higher probability of undergoing regular diagnostic testing and health check-ups.

• Hematology

Hematology analyzers, particularly the ones offering POC testing, facilitate timely disease management and treatment. Developing automated and portable analyzers permits on-site testing, thereby cutting down on turnaround time and enhancing efficiency in the veterinary clinics. Integrating AI-based diagnostics is further improving speed and precision of hematological assessments. Detecting diseases early through hematological analysis has the capacity of improving overall animal health.

• Immunology & Serology

Immunology and serology tests like the ones for parvovirus, FeLV, and the other infectious diseases facilitate precise and quick diagnosis, thereby letting vets intervene early and enhance treatment outcomes. Such tests are capable of assessing the immune status of an animal, inclusive of antibody levels post-vaccination or initial exposure to antibodies, which is important in order to manage infectious diseases and dole out appropriate vaccination strategies.

Immunology and serology also play a vital role in livestock health by facilitating early diagnosis of diseases such as bovine tuberculosis and foot-and-mouth disease, thereby helping in averting outbreaks and minimizing the monetary losses.

• Imaging

Rise in pet ownership, increased awareness about animal health, and growing pet insurance penetration are accelerating the demand for precise diagnoses. Advancements such as portable ultrasound machines, AI-powered image analysis, and cloud-based storage are enhancing affordability and accessibility. The American veterinary medical Association (AVMA) has reported a 25% increase in CT scans and ultrasounds for livestock owing to concerns regarding Johne’s disease and bovine tuberculosis.

• Molecular Diagnostics

Molecular diagnostics are able to provide precise, rapid, and sensitive disease detection in both farm and companion animals, thereby resulting in better management and prevention of diseases. Enhancements in techniques such as DNA sequencing, PCR, and various other nucleic acid-based methods are rendering molecular diagnostics more affordable and accessible for the veterinary clinics. Molecular diagnostics permit early detection of ailments, including zoonotic diseases (the ones transmissible to humans) as well as genetic conditions, thereby facilitating timely intervention as well as treatment.

By Animal Type

• Production Animals

Production animals such as swine, cattle, and poultry are noticeably contributing to the growth of the US veterinary diagnostics market. This could be credited to growing demand for various animal-derived food products, advancements with respect to diagnostic technologies, and the need for effective management of diseases in livestock.

Advancements referred to include ELISA, PCR, and biosensor-based systems, which are making provisions for precise, quicker, and user-friendly tools for diagnosing diseases in livestock. They are making it simpler for vets to detect as well as treat a broader spectrum of diseases, thereby bolstering the market.

• Companion Animals

Pet owners are showing a higher level of willingness regarding investment in the health of their animals, thereby resulting in greater demand for diagnostic services and tools. The trend is catalyzed by advancements such as imaging technologies and POC testing, which facilitate quicker diagnoses. The government is also focusing on animal welfare to support growth of the US veterinary diagnostics market. Research states that close to 70% of households in the US own pets, which implies a requirement for veterinary care encompassing diagnostics.

By End-use

• Reference Laboratories

Reference laboratories are capable of processing samples at a large scale, thereby rendering them ideal for disease outbreaks and routine testing. They adopt advanced techniques such as ELISA, PCR, and sophisticated imaging technologies, thereby facilitating comprehensive and more precise diagnoses. They also employ specialists in several fields, such as microbiology, pathology, and molecular diagnostics, thereby rendering expertise that is unavailable in several smaller veterinary settings.

• Veterinarians

Veterinarians are using portable diagnostic devices for on-site testing, thereby facilitating faster diagnosis as well as treatment, particularly during emergencies. Such tests permit detection of multiple pathogens simultaneously, thereby enhancing the speed and precision of detecting infectious diseases. Enhanced imaging technologies do make provisions for detailed views of internal organs for veterinarians, thereby helping in diagnosing complex conditions.

• Animal Owners/Producers

Animal owners/producers are contributing to the growth of the US veterinary diagnostics market in the form of higher spending on pet healthcare, an increase in pet ownership, and the adoption of various advanced diagnostic technologies. Advancements such as image recognition technology, rapid molecular tests, and AI-powered diagnostics are improving the precision and efficiency of veterinary diagnostics. Also, diagnostic tools are witnessing integration with on-farm practices for better product optimization, better herd health management, and food safety.

How are Reference Laboratories Shaping the US Veterinary Diagnostics Market?

Reference laboratories are amongst the major revenue generators in the US veterinary diagnostics market. This could be credited to higher volumes of samples received by the laboratories for testing, a rise in the establishment of diagnostic laboratories, and higher buying power of reference laboratories regarding the adoption of testing kits that are technologically advanced.

Report Scope

Key Developments

The US veterinary diagnostics market is witnessing a significant organic and inorganic expansion. Some of the key developments include –

• In March 2025, Antech Diagnostics, Inc. introduced TryRapid FOUR, one of the in-house canine vector-borne disease (CVBD) screening tests. It helps in the detection of canine antibodies to Anaplasma spp., Lyme C6 (Borrelia burgdorferi), Ehrlichia spp., and heartworm (Dirofilaria immitis) antigens using lateral flow technology.

• In January 2025, Neogen Corporation introduced Igenity BCHF, which is a test meant for detecting genetic predisposition for Bovine Congestive Heart Failure (BCHF). It would aid in improving bovine heart health standards.

• In September 2024, Zoetics Inc. launched Vetscan OptiCell, which comes across as a novel cartridge-based hematology analyzer employing AI-powered technology meant for delivering accurate Complete Blood Count (CBC) analysis at point-of-care centers, thereby offering lab-quality results at low cost and within no time.

• In February 2024, MiDOG Animal Diagnostics launched an advanced All-in-One Diagnostic Test that could facilitate rapid detection of fungal and bacterial infections, inclusive of antibiotic resistance, across several animal species.

Leading Players

The US veterinary diagnostics market is highly competitive, with a large number of service providers globally. Some of the key players in the market include:

• IDEXX Laboratories Inc.
• Zoetis Services LLC
• Thermo Fisher Scientific Inc.
• Antech Diagnostics Inc.
• Neogen Corporation
• Bio-Rad Laboratories Inc.
• Heska Corporation
• Chembio Diagnostic Systems Inc.
• Abbott Laboratories
• Danaher Corporation
• Creative Diagnostics
• General Electric
• Others

These firms apply a plethora of strategies to enter the market, including innovations, mergers and acquisitions, and collaboration.

The US veterinary diagnostics market is shaped by the presence of diversified players that compete based on product innovation, vertical integration, and cost efficiency.

The US Veterinary Diagnostics Market is segmented as follows:

By Product

• Consumables
• Reagents
• Kits
• Equipment & Instruments

By Testing Category

• Clinical Chemistry
• Microbiology
• Parasitology
• Histopathology
• Cytopathology
• Hematology
• Immunology & Serology
• Imaging
• Molecular Diagnostics

By Animal Type

• Production Animals
• Cattle
• Poultry
• Swine
• Companion Animals
• Dogs
• Cats
• Horses

By End-use

• Reference Laboratories
• Veterinarians
• Animal Owners/Producers